Single shot Johnson & Johnson Covid vaccine recommended for FDA authorisation
The single shot Johnson & Johnson Covid vaccine has been recommended by experts for Food and Drug Administration authorisation.
The unanimous recommendation on Friday paves the way for the FDA to fully approve the vaccine, making it the third one available in the US.
If the FDA signs off on it this weekend, millions of doses of the vaccine, which does not need specialist cold storage, could be available across the country next week.
The rollout of a third vaccine comes as the US has just passed 500,000 deaths during the pandemic.
To date, only vaccines by Pfizer and Moderna have been approved for emergency use in the US by federal authorities and a third would help health officials speed up the rate of vaccination.
Earlier this week Joe Biden marked the country passing the 50 million vaccine mark, and the president has vowed to vaccinate 100 million people in his first 100 days in office.
Read More
Tennessee: Vaccines stolen, given to children in 1 county
Third US vaccine could raise question: Which shots are best?
Covid vaccines ‘encouraged’ but not compulsory for Olympic athletes, IOC confirm
President Biden warns of new variants as administration hits 50m Covid vaccines